Skip to main content
. 2019 Nov 7;20(22):5555. doi: 10.3390/ijms20225555

Figure 1.

Figure 1

Viability and characterization of prostaglandin E synthases 2 (PGE2) treatment in normal human dermal fibroblasts (NHDFs). NHDFs were seeded in 96-well plates at a density of 2 × 103 cells per well and treated with PGE2 (A,B). Cell viability results, based on a Cell Counting Kit-8 (CCK-8) assay, are presented as the mean ± standard deviation (SD) of the percentage of the control optical density (OD). (C) NHDF morphologies were visualized with phase contrast microscopy (×40, ×200). NHDFs were treated with 50 μg/mL of PGE2 or dimethyl sulfoxide (DMSO) for 24 h. Values represent the mean ± SD of three independent experiments. * p < 0.05 compared to the control.